Cannabis-induced depersonalization disorder in adolescence

Neuropsychobiology

Volumn 65, Issue 3, 2012, Pages 141-146

  Hürlimann, Franziska ^a   Kupferschmid, Stephan ^a   Simon, Andor E ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Psychiatric Outpatient Services Bruderholz   (Switzerland)

Author keywords

Adolescence; Cannabis; Depersonalization disorder

Indexed keywords

CANNABIS; DRONABINOL; ILLICIT DRUG;

ADOLESCENCE; ADOLESCENT; ARTICLE; BRAIN; CLINICAL ARTICLE; DEPERSONALIZATION; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PSYCHOSIS; SMOKING;

ADOLESCENT; ADULT; DEPERSONALIZATION; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; YOUNG ADULT;

EID: 84857472161     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000334605     Document Type: Article

References (42)

1. Roxburgh A, Hall WD, Degenhardt L, et al: The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Addiction 2010; 105: 1071-1079.
2. Gaoni Y, Mechoulam R: Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964; 86: 1646-1647.
3. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC: Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988; 34: 605-613. (Pubitemid 19007296)
4. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC: Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 1991; 11: 563-583.
5. Devane WA, Hanus L, Breuer A, et al: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946-1949. (Pubitemid 23026736)
6. Macleod J, Oakes R, Copello A, et al: Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. Lancet 2004; 363: 1579-1588. (Pubitemid 38625660)
7. Morgan CJA, Schafer G, Freeman TP, Curran V: Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: Naturalistic study. Br J Psychiatry 2010; 197: 285-290.
8. Moore THM, Zammit S, Lingford-Hughes A, et al: Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 2007; 370: 319-328. (Pubitemid 47094993)
9. Smit F, Bolier L, Cuijpers P: Cannabis use and the risk of later schizophrenia: A review. Addiction 2004; 99: 425-430. (Pubitemid 38496658)
10. Arseneault L, Cannon M, Witton J, Murray RM: Causal association between cannabis and psychosis: Examination of the evidence. Br J Psychiatry 2004; 184: 110-117. (Pubitemid 38186851)
11. Semple DM, McIntosh AM, Lawrie SM: Cannabis as a risk factor for psychosis: A systematic review. J Psychopharmacol 2005; 19: 187-194. (Pubitemid 40577224)
12. Bossong MG, Niesink RJM: Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Progr Neurobiol 2010; 92: 370-385.
13. Large M, Sharma S, Compton M, Slade T, Nielssen O: Cannabis use and earlier onset of psychosis: A systematic meta-analysis. Arch Gen Psychiatry 2011; 68: 555-561.
14. Johnson JG, Cohen P, Kasen S, Brook JS: Dissociative disorders among adults in the community, impaired functioning, and axis I and II comorbidity. J Psychiatry Res 2006; 40: 131-140. (Pubitemid 43172874)
15. Michal M, Wiltink J, Subic-Wrana C, et al: Prevalence, correlates and predictors of depersonalization experiences in the German general population. J Nerv Ment Dis 2009; 197: 499-506.
16. Simeon D, Knutelska M, Nelson D, Guralnik O: Feeling unreal: A depersonalization disorder update of 117 cases. J Clin Psychiatry 2003; 64: 990-997. (Pubitemid 37158243)
17. Baker D, Hunter E, Lawrence E, et al: Depersonalisation disorder: Clinical features of 204 cases. Br J Psychiatry 2003; 182: 428-433. (Pubitemid 36560979)
18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
19. Ajdacic-Gross V, Lauber C, Warnke I, Haker H, Murray RM, Rössler W: Changing incidence of psychotic disorders among the young in Zurich. Schizophr Res 2007; 95: 9-18. (Pubitemid 47313630)
20. Simeon D, Kozin D, Segal K, Lerch B: Is depersonalization disorder initiated by drug use any different? A survey of 394 adults. J Clin Psychiatry 2009; 70: 1358-1364.
21. Medford N, Baker D, Hunter E, et al: Chronic depersonalization following illicit drug use: A controlled analysis of 40 cases. Addiction 2003; 98: 1731-1736. (Pubitemid 38030781)
22. Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkötter J: Schizophrenia Proneness Instrument (SPI-A). Rome, Fioriti, 2007.
23. Miller TJ, McGlashan TH, Woods SW, et al: Symptom assessment in schizophrenic prodromal states. Psychiatr Q 1999; 70: 273-287.
24. McGlashan TH, Miller TJ, Woods SW, Rosen JL, Hoffman RE, Davidson L: Structured Interview for Prodromal Syndromes (Version 3.0, unpublished manuscript). New Haven, Connecticut: PRIME Research Clinic, Yale School of Medicine, 2001.
25. Sierra M, Berrios GE: The Cambridge Depersonalization Scale: A new instrument for the measurement of depersonalization. Psychiatry Res 2000; 93: 153-164. (Pubitemid 30139482)
26. Sierra M, Baker D, Medford N, David AS: Unpacking the depersonalization syndrome: An exploratory factor analysis on the Cambridge Depersonalization Scale. Psychol Med 2005; 35(10):1523-1532. (Pubitemid 41430689)
27. Simeon D, Kozin DS, Segal K, Lerch B, Dujour R, Giesbrecht T: Deconstructing depersonalization: Further evidence for symptom clusters. Psychiatry Res 2008; 157: 303-306. (Pubitemid 350166565)
28. Simeon D, Riggio-Rosen A, Guralnik O, Knutelska M, Nelson D: Depersonalization disorder: Dissociation and affect. J Trauma Dissociation 2003; 4: 63-76. (Pubitemid 38072050)
29. Hunter EC, Sierra M, David AS: The epidemiology of depersonalisation and derealisation: A systematic review. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 9-18. (Pubitemid 39369102)
30. Sierra M: Depersonalization: A new look at a neglected syndrome, ed 1. New York. Cambridge University Press, 2009.
31. Akirav I, Maroun M: The role of the medial prefrontal cortex-amygdala circuit in stress effects on the extinction of fear. Neural Plast 2007; 30873.
32. Mathew RJ, Wilson WH, Humphreys D, Lowe JV, Weithe KE: Depersonalization after marijuana smoking. Biol Psychiatry 1993; 33: 431-441. (Pubitemid 23149164)
33. Mathew RJ, Wilcon WH, Chiu NY, Turkington TG, Degrado TR, Coleman RE: Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. Acta Psychiatr Scand 1999; 100: 67-75. (Pubitemid 29309200)
34. Kupferschmid S, Hubl D, Federspiel A, Jann K, Hauf M, Schimmelmann BG: Chronic derealisation phenomenon in a 17-year-old boy after twofold cannabis use: When acute becomes chronic. Schizophr Res 2010; 117: 348.
35. Sierra M, Berrios GE: Depersonalization: Neurobiological perspectives. Biol Psychiatry 1998; 44: 898-908. (Pubitemid 28520228)
36. Sierra M, David AS: Depersonalization: A selective impairment of self-awareness. Consciousness and Cognition 2011; 20: 99-108.
37. Medford N, Brierley B, Brammer M, Bullmore ET, David AS, Phillips ML: Emotional memory in depersonalization disorder: A functional MRI study. Psychiatry Res 2006; 148: 93-102. (Pubitemid 44750587)
38. Lemche E, Surguladze SA, Giampeitro VP, et al: Limbic and prefrontal responses to facial emotion expressions in depersonalization. Neuroreport 2007; 18: 473-477. (Pubitemid 46668037)
39. Lemche E, Anilkumar A, Giampietro VP, et al: Cerebral and autonomic responses to emotional facial expressions in depersonalisation disorder. Br J Psychiatry 2008; 193: 222-228.
40. Phillips ML, Medford N, Senior C, et al: Depersonalization disorder: Thinking without feeling. Psychiatry Res 2001; 108: 145-160. (Pubitemid 34072915)
41. Simeon D: Depersonalisation disorder: A contemporary overview. CNS Drugs 2004; 18: 343-354. (Pubitemid 38621682)
42. Ameri A: The effects of cannabinoids on the brain. Progr Neurobiol 1999; 58: 315-348. (Pubitemid 29230000)